In the United States, Group B Streptococcus (GBS) bacteria are a leading cause of meningitis and sepsis in a newborn’s first three months of life. The bacteria may be passed from pregnant women to their babies during delivery, because about one in every four pregnant women carry GBS bacteria in their body.
The ability to combat the SARS-CoV-2 virus through accelerated advancements in diagnostics, treatment and vaccine development relies on understanding how the virus is transmitted between people and accurately tracking mutations. Whole genome sequencing and subsequent analysis can provide a wealth of data and contribute important insights to this effort.
When pathogens get past those preliminary defenses, your body mounts an immune response. Your innate immune system responds first and employs several types of cells and molecules to fight off pathogens, each with their own jobs.